Commonwealth Equity Services’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36
Closed -$6 3901
2023
Q1
$6 Sell
36
-3
-8% -$631 ﹤0.01% 3742
2022
Q4
$8K Sell
39
-25
-39% -$9.44K ﹤0.01% 3662
2022
Q3
$24K Buy
64
+23
+56% +$13K ﹤0.01% 3558
2022
Q2
$17K Hold
41
﹤0.01% 3586
2022
Q1
$24K Buy
+41
New +$30.5K ﹤0.01% 3645
2020
Q1
Sell
-38
Closed -$20K 2920
2019
Q4
$20K Buy
+38
New +$15.8K ﹤0.01% 2852

Other funds holding PAVM

Commonwealth Equity Services's PAVM Position: Q2 2023 in Review

Commonwealth Equity Services sold out of PAVmed (PAVM) in Q2 2023, closing a stake of 36 shares — an estimated $6 sold.

Commonwealth Equity Services first reported a position in PAVM in Q4 2019 and held it in 6 quarters. The position peaked at $24K in Q3 2022. 55 funds tracked by Wall St. Rank hold PAVM as of Q2 2023.

  • Commonwealth Equity Services reported no remaining PAVmed position as of Q2 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 36 PAVmed shares in Q2 2023, an estimated $6.
  • Commonwealth Equity Services first reported a position in PAVmed in Q4 2019 and held it in 6 quarters.
  • Commonwealth Equity Services's PAVmed position peaked at $24K in Q3 2022.
  • 55 funds tracked by Wall St. Rank held PAVmed as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.